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Research articleExercise and global well-being in 
community-dwelling adults with fibromyalgia: a 
systematic review with meta-analysis
George A Kelley*1, Kristi S Kelley1, Jennifer M Hootman2 and Dina L Jones3
Abstract
Background: Exercise has been recommended for improving global-well being in adults with fibromyalgia. However, 
no meta-analysis has determined the effects of exercise on global well-being using a single instrument and when 
analyzed separately according to intention-to-treat and per-protocol analyses. The purpose of this study was to fill that 
gap.
Methods: Studies were derived from six electronic sources, cross-referencing from retrieved studies and expert review. 
Dual selection of randomized controlled exercise training studies published between January 1, 1980 and January 1, 
2008 and in which global well-being was assessed using the Fibromyalgia Impact Questionnaire (FIQ) were included. 
Dual abstraction of data for study, subject and exercise program characteristics as well as assessment of changes in 
global well-being using the total score from the FIQ was conducted. Risk of bias was assessed using the Cochrane bias 
assessment tool. Random-effects models and Hedge's standardized effect size (g) were used to pool results according 
to per-protocol and intention-to-treat analyses.
Results: Of 1,025 studies screened, 7 representing 5 per-protocol and 5 intention-to-treat outcomes in 473 (280 
exercise, 193 control) primarily female (99%) participants 18-73 years of age were included. Small, statistically significant 
improvements in global well-being were observed for per-protocol (g and 95% confidence interval, -0.39, -0.69 to -0.08) 
and intention-to-treat (-0.34, -0.53 to -0.14) analyses. No statistically significant within-group heterogeneity was found 
(per-protocol, Qw = 6.04, p = 0.20, I2 = 33.8%; intention-to-treat, Qw = 3.19, p = 0.53, I2 = 0%) and no between-group 
differences for per-protocol and intention-to-treat outcomes were observed (Qb = 0.07, p = 0.80). Changes were 
equivalent to improvements of 8.2% for per-protocol analyses and 7.3% for intention-to-treat analyses.
Conclusions: The results of this study suggest that exercise improves global well-being in community-dwelling 
women with fibromyalgia. However, additional research on this topic is needed, including research in men as well as 
optimal exercise programs for improving global well-being in adults.
Background
Fibromyalgia is a chronic rheumatic condition character-
ized by widespread pain, fatigue, and multiple tender
points [1]. A recent study by the National Arthritis Data
Workgroup estimated the prevalence of primary fibromy-
algia to be approximately 5 million among US adults 18
years of age and older in 2005 [2]. Approximately 87% of
those diagnosed with fibromyalgia in the US are women
(population prevalence = 3.4% females versus 0.5%
males), with diagnosis most often occurring during mid-
dle age [2]. Adults with fibromyalgia have 2-3 times
higher healthcare costs [3,4] and report poorer well-being
(16.5% to 52% lower scores on the SF-36) compared to
healthy persons [5,6].
Exercise is a non-pharmacologic intervention that has
been recommended for community-dwelling adults with
fibromyalgia [1]. One of the most commonly measured
outcomes when assessing the effects of exercise in those
with fibromyalgia is global well-being [7]. Recent ran-
domized controlled trials examining the effects of exer-
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cise on global well-being among those with fibromyalgia
have yielded conflicting findings [8-14]. For example,
using the total score from the Fibromyalgia Impact Ques-
tionnaire (FIQ), the most commonly used instrument for
assessing global well-being in fibromyalgia participants
[7], four studies reported a statistically significant
improvement in global well-being [8,9,12,14], while
another three reported no statistically significant
improvement [10,11,13].
A previous systematic review [7] examined the effects
of exercise on global well-being using the total score from
the FIQ, study participant-rated change in fibromyalgia
symptoms and observer-rated changes in fibromyalgia
symptoms. The authors reported statistically significant
improvements as a result of aerobic exercise (standard-
ized mean difference, 0.49, 95% confidence interval, 0.23
to 0.75) and strength training (standardized mean differ-
ence, 1.43, 95% confidence interval, 0.76 to 2.10). These
were equivalent to relative improvements in global well-
being of 12% for aerobic exercise from 4 studies
[9,10,13,15] and 122% for strength training from only 2
studies [16,17]. Generally, recommendations regarding
the clinical importance of relative improvements have
ranged from 15% [18] to 30% [19].
Since the time of the last search for the previous review
(July, 2005), additional randomized controlled trials on
this topic have been published [11,12,14], with only one
of the three studies reporting a statistically significant
improvement in global well-being based on the total
score from the FIQ [12]. In addition, the authors of the
previous systematic review included multiple measures of
global well-being [7], an approach that may be problem-
atic given that recent research has suggested that the
pooling of global well-being instruments could result in
biased meta-analyses [20]. More specifically, the use of
different instruments to assess global well-being might
attenuate any estimated effects or add spurious between-
study variance because of between-measure "noise." Fur-
thermore, the authors preferentially included results
based on intention-to-treat analyses if they were available
despite the fact that the opportunity existed to examine
intention-to-treat and per-protocol results separately.
This may be problematic given that recent meta-epidemi-
ological research found that excluding participants from
randomized controlled trials in systematic reviews often
results in biased estimates of treatment effects [21].
Based on this finding, the authors recommended that sys-
tematic reviews routinely assess the influence of the
exclusion of participants on estimated treatment effects
[21].
Thus, given that (1) additional randomized controlled
trials on the effects of exercise on global well-being have
been published since the last systematic review [7], (2)
the potential problems in pooling results from different
measures of global well-being [20], and (3) the fact that
no one to date has examined per-protocol and intention-
to-treat results separately, the purpose of this study was
to use the meta-analytic approach to examine the effects
of exercise on global well-being as assessed by the FIQ in
community-dwelling adults with fibromyalgia.
Methods
Data Sources and Searches
Studies for the current meta-analysis were retrieved from
a large in-house and broad exercise and rheumatic dis-
ease database that includes 1025 citations. This initial
database was developed by searching six electronic
sources (PubMed, EmBase, Cochrane Central Register of
Controlled Clinical Trials, CINAHL, SPORTDiscus and
Dissertation Abstracts Online), cross-referencing from
retrieved studies, including review articles, and expert
review (Dr. Miriam Nelson, Tufts University, personal
communication, June 13, 2008). All computer searches
were conducted by the second author with the assistance
of the first author. Search queries for the six electronic
sources from which studies were derived for this database
are shown in Additional File 1. From the 1025 citations in
the database, a search for studies dealing with the effects
of exercise on global well-being using the FIQ in partici-
pants with fibromyalgia was conducted using the single
keyword "fibromyalgia" while searching across all indexed
fields within the database.
Study Selection
The inclusion criteria for this study were: (1) randomized
controlled trials with the unit of assignment at the partic-
ipant level, (2) an exercise-only intervention group (aero-
bic, strength training, or both), (3) community-accessible
exercise interventions, defined as those interventions that
could be performed and made available to non-institu-
tionalized persons in a community setting, (4) exercise
intervention of at least four weeks, (5) a comparative con-
trol group (usual care or attention control), (6) commu-
nity-dwelling adults aged 18 years and older with
fibromyalgia, (7) published and unpublished studies
(master's degrees and dissertations), (8) studies published
in any language between January 1, 1980 and January 1,
2008, and (9) data available on global well-being as
assessed by the total score from the FIQ [22]. The FIQ,
described in detail elsewhere [22], is a self-administered
instrument aimed at assessing global well-being in partic-
ipants with fibromyalgia. It takes approximately 5 min-
utes to complete [22]. The validity and reliability of the
FIQ has been previously established, including its ability
to detect therapeutic change [22]. Studies were limited to
those in which aerobic and/or strength training were the
only interventions because they are the two most com-
mon nonpharmacologic interventions recommended for
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maintaining overall fitness [23-25] and are most likely to
be performed in the community. In addition, to answer
the research question for this study, the difference
between the experimental and control group had to be
the exercise intervention in the experimental group. The
search for studies started in 1980 based on the recom-
mendations from rheumatic disease experts associated
with this project as well as an external consultant (Dr.
Miriam Nelson, Tufts University, personal communica-
tion, June 13, 2008). In addition, this was the approximate
time in which the FIQ was first developed [22]. All trials
other than randomized controlled trials were excluded
because nonrandomized trials cannot fully control for
confounders that are not known or measured and have
been shown to overestimate estimates of treatment
effects [26,27]. Review articles were excluded because
they did not contain complete data for each study
reviewed. Rather, cross-referencing from review articles
was performed to identify studies that might be included.
Follow-up studies in which the initial intervention ended
but participants continued to be tracked post-interven-
tion were excluded because the focus of this project was
on the exercise intervention versus exercise behavior
post-intervention. Since the focus of the current meta-
analysis was on participants with fibromyalgia, studies in
participants without fibromyalgia were excluded. Studies
less than 4 weeks were excluded based on the expectation
that exercise-induced changes in global well-being, if any,
might be reasonably expected to occur by this time. To
avoid multiple publication bias, studies that included the
same subjects as another study were excluded. Trials that
did not collect and report data using the FIQ were
excluded based on previous research suggesting that the
pooling of global well-being instruments could result in
biased meta-analyses [20]. Abstracts were excluded
because of the minimal information provided and the dif-
ficulty in retrieving this information. Acute studies,
defined as those studies in which global well-being was
assessed immediately after a single-exercise session, were
excluded given the research teams interest in the chronic
effects of exercise on global well-being. Studies in chil-
dren and/or adolescents were excluded because of the
many maturational changes that occur during this time.
Finally, rehabilitation studies were excluded because of
the investigative team's interest in exercise programs that
could be replicated in the community, a public health
approach that might have the greatest reach in terms of
participants with fibromyalgia. The selection of studies
was conducted by the first two authors. Using Cohen's
kappa statistic [28], the overall agreement rate (yes/no
based on whether to include or exclude) prior to adjudi-
cation was 0.89.
Data Abstraction
Prior to the abstraction of data, a codebook was devel-
oped that included the following major categories: (1)
study characteristics, (2) subject characteristics, (3) exer-
cise program characteristics and (4) outcomes (e.g.,
changes in global well-being as assessed by the total score
from the FIQ). All studies were coded by the first two
authors, independent of each other. The authors then
reviewed every item for accuracy and precision. Dis-
agreements were resolved by consensus. Using Cohen's
kappa statistic [28], the overall agreement rate prior to
correcting discrepant items was 0.96, considered to be
almost perfect [29].
Risk of Bias Assessment
Because of the lack of empirical evidence [27,30], includ-
ing validity [31], to support the use of quality scales, the
risk of bias assessment tool recently recommended by the
Cochrane Collaboration was used to assess bias across six
domains: (1) sequence generation, (2) allocation conceal-
ment, (3) blinding to group assignment, (4) incomplete
outcome data, (5) selective outcome reporting, and (6)
other potential bias [32]. Each domain was classified as
having either a high, low, or unclear risk of bias [32]. The
decision rule for blinding was that participants, research
personnel, and outcome assessors were blinded to the
primary outcome of interest, that is, global well-being as
assessed by the FIQ. Blinding of all three groups was con-
sidered important given the subjective nature of mea-
sures of global well-being. Selective reporting was also
limited to global well-being as assessed by the FIQ and
was based on the outcome being reported in the methods
and data in the results [33]. Other potential forms of bias
were limited to between-group differences in baseline
global well-being as assessed by the FIQ. All assessments
were conducted by the first two authors, independent of
each other. Both authors then met and reviewed every
item for agreement. Disagreements were resolved by con-
sensus. Using Cohen's kappa statistic [28], overall inter-
rater agreement prior to correcting discrepant items was
0.10, considered to be slight [29]. On an itemized basis
and using the general categories suggested by Landis [29],
inter-rater agreement was 1.0 (perfect) for between-
group baseline differences in the FIQ, 0.71 (substantial)
for sequence generation, 0.14 (slight) for allocation con-
cealment and incomplete outcome reporting, and 0
(poor) for blinding and selective outcome reporting. The
range of inter-rater agreement for each domain was simi-
lar but wider than recent methodological research using
this assessment tool (0.13 to 0.74) [33]. The wide range of
inter-rater reliability scores is most likely due to the
degree of subjective decision-making that is allowed with
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this tool, and for the current study, the fact that this was
the first time that the research team used this instrument.
Data Synthesis and Analysis
Calculation of study-level effect-size estimates for the FIQ
The primary outcome in this study was the total score
from the FIQ [22]. Given the different versions and meth-
ods of reporting, the standardized effect size (g) was used
for all FIQ outcomes [34]. For the one study that included
two exercise groups[13], g was pooled in order to main-
tain independence. Since all studies were parallel trials,
the g for each outcome from each study was calculated as
the difference in change scores between the exercise and
control groups divided by the pooled standard deviations
of these change scores [34]. This calculation included an
adjustment for small within-group sample sizes [34].
Since change score standard deviations were not reported
for any of the included studies, these were estimated for
six studies [9-14] using pre- and post-intervention means
and standard deviations in the exercise and control
groups [35]. Standard deviations were calculated for
another study using the 95% confidence intervals that
were reported [8]. The variance of each g from each study
was then estimated using previously developed proce-
dures [34]. Since a lower total FIQ score represents
higher global well-being, a negative g indicates that exer-
cise improved global well-being in participants.
Pooled estimates for FIQ
A random effects model was used to pool FIQ outcomes
from each study and were reported according to whether
the data were analyzed using a per-protocol or intention-
to-treat approach. If the two-tailed 95% confidence inter-
vals generated from the models did not cross zero, results
were considered to be statistically significant. In terms of
magnitude, values for g of 0.20, 0.50, and 0.80 have been
suggested to represent small, medium, and large effect
sizes [36]. Heterogeneity of FIQ outcomes between stud-
ies was examined using the Q statistic and a commonly
used alpha value for statistical significance of 0.10 [34]. In
addition, the consistency of between-study findings for
FIQ outcomes were analyzed using I2[37]. Generally, I2
values of 25%, 50%, and 75% may be considered to repre-
sent small, medium, and large amounts of inconsistency.
For this study, the decision rule for heterogeneity was a
Qw value ≤ 0.10 and/or an I2 value greater than 50%. In
addition, mixed-effects models were used to test for
between-group differences (Qb) in FIQ outcomes accord-
ing to per-protocol and intention-to-treat analysis. Since
there was no statistically significant heterogeneity for
per-protocol or intention-to-treat results and the number
of included studies was small, no analyses for potential
covariates were conducted. An alpha value of ≤ 0.05 was
considered to be statistically significant for the between-
group comparison.
In order to enhance interpretability, the common lan-
guage effect size (CLES) was calculated for all FIQ out-
comes [38]. Using the CLES, a g of 0.50, for example,
means that 64% of the subjects in an experimental group
will score higher than subjects in a control group if cho-
sen at random. In addition, g was converted to an odds
ratio (OR) to further enhance interpretation.
Publication bias
Publication bias was examined using the nonparametric
trim and fill linear estimator L approach of Duvall and
Tweedie [39].
Sensitivity analysis
In order to examine the influence of each study on the
overall results, each study was deleted from the model
once and the pooled analyses conducted with that one
study deleted from the model. Because of the small num-
ber of studies as well as the lack of between-study hetero-
geneity, bias assessment results were not incorporated
into the statistical analysis of data.
Cumulative meta-analysis
In order to examine changes in findings over time, cumu-
lative meta-analysis, ranked by year, was performed [40].
Cumulative meta-analysis is an approach in which study
results are added one at a time in a specified order and
summarized as each new study is added [40].
Software utilization for statistical analysis
Descriptive statistics were generated using SPSS (version
16.0) [41]. All meta-analytic analyses were conducted
using Comprehensive Meta-Analysis (version 2.2) [42].
Results
Study Characteristics
Of the 1,025 studies screened, 7 representing 10 FIQ out-
comes (5 per-protocol and 5 intention-to-treat scores)
were included (Figure 1) [8-14]. All of the studies were
published in English-language journals between 2001 and
2007 [8-14]. Four studies were conducted in Canada [8-
10,13], two in Spain [12,14] and one in the United States
[11]. Another four studies reported using both per-proto-
col and intention-to-treat approaches in the analysis of
their data [9-11,13], two were limited to per-protocol
[12,14] and one to intention-to-treat [8].
Results for risk of bias are shown in Table 1. Within
each domain and across all studies, a low risk of bias for
selective reporting of data using the FIQ as well as
between-group differences in baseline FIQ was observed.
Alternatively, all studies were considered to be at a high
risk of bias for blinding of participants, personnel and
outcome assessors to group assignment. Adequate
sequence generation was unclear in more than half of the
studies while adequate allocation concealment was
unclear in almost three fourths. Three fourths of studies
were also considered to be at a low risk of bias for ade-
quately reporting incomplete outcome data. Within each
Kelley et al. BMC Public Health 2010, 10:198
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individual study and across all domains, low, high, and
unclear risks of bias ranged, respectively, from 33% to
83%, 17% to 33%, and 0% to 50%.
Participant Characteristics
A general description of the participants for each group
from each study is provided in Table 2. The total number
of participants was 473 (280 exercise, 193 control), rang-
ing from 15 to 56 in the exercise groups (  ± SD, 40 ±
32) and 14 to 40 in the control groups (  ± SD, 28 ± 11).
The percentage of dropouts ranged from 5.6% to 46.7% in
the exercise groups (  ± SD, 27.9% ± 16.9%) and 0% to
63.0% in the control groups (  ± SD, 19.2% ± 22.0%).
One study included six men (three exercise, three con-
trol) [9] while the remaining six studies were limited to
women [8,10-14]. In total, approximately 99% of the par-
ticipants were women. The within-study age of the par-
ticipants ranged from 18 to 73 years in both the exercise
and control groups while the mean between-group age
ranged from 41 to 51 years in the exercise groups (  ±
SD, 46.0 ± 3.7) and 42 to 52 years in the control groups
(  ± SD, 48.0 ± 3.3). For race and ethnicity, one study
reported that all participants were Caucasian [12] while
another reported that greater than 90% of the partici-
pants were Caucasian with the remaining consisting of
Aboriginals and Hispanics [13]. Another study appeared
to consist entirely of Hispanics [14].
In relation to medications, five studies reported that
one or more participants were taking some type of medi-
cation(s) for fibromyalgia [8-11,14], although it is likely
that all studies had one or more participants taking some
type of medication(s).
The mean between-group duration of self-reported
fibromyalgia symptoms ranged from 8 to 24 years in the
exercise groups (  ± SD, 11.5 ± 5.4) and 7 to 19 years in
the control groups (  ± SD, 11.1 ± 4.1) [8-14]. For the
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Figure 1 Flow diagram for the selection of studies. aThe number of 
reasons for exclusion exceeds the number of studies excluded be-
cause some studies were excluded for multiple reasons.
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Table 1: Risk of bias assessment.
Reference Sequence 
Generation
Allocation 
Concealment
Blinding Incomplete
Outcome
Data
Selective 
Reporting
Other 
Bias
Low 
Risk
High 
Risk
Unclear
Da Costa et al. (2005)[8] Low Low High Low Low Low 83% 17% 0%
Gowans et al.(2001)[9] Unclear Unclear High Unclear Low Low 33% 17% 50%
King et al. 2002)[10] Low High High Low Low Low 67% 33% 0%
Kingsley et al. (2005)[11] Low Unclear High Low Low Low 67% 17% 17%
Munguia-Izquierdo & 
Legaz-Arrese (2007)[12]
Unclear Unclear High Unclear Low Low 33% 17% 50%
Schachter et al. (2003)[13] Unclear Unclear High Low Low Low 50% 17% 33%
Tomas-Carus et al. (2007) [14] Unclear Unclear High Low Low Low 50% 17% 33%
Low Risk 43% 14% 0% 71% 100% 100% - - -
High Risk 0% 14% 100% 0% 0% 0%
Unclear 57% 71% 0% 29% 0% 0% - - -
NOTES: Blinding and Selective Reporting limited to global well-being using the FIQ; Other Bias limited to between-group baseline differences in 
global well-being using the FIQ.
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Table 2: General Characteristics of Studies.
Reference N Age
(Years)
Gender
(F/M)
Duration FM (Years) Exercise Intervention
Da Costa et al. (2005)[8] Ex: 39
Con (usual care): 40
Ex: 49.2 ± 8.7
Con: 52.3 ± 10.8
F Ex:10.5 ± 8.4
Con: 11.2 ± 7.6
12 weeks home-based aerobic exercise, 60-120 min/week, 
60-85% MHR; strengthening & stretching; compliance to 
aerobic exercise, 65.9%
Gowans et al.(2001)[9] Ex: 27
Con (usual care): 23
Ex: 44.6 ± 8.7
Con: 49.8 ± 7.3
F (88%)/M Ex: 9.6 ± 8.6
Con: 8.4 ± 7.6
23 weeks supervised, facility-based aerobic exercise, 3×/
wk, 20 min/day, 60-75% MHR; compliance, 67%.
King et al. 2002)[10] Ex: 46
Con (attention control): 39
Ex: 45.2 ± 9.4
Con: 47.3 ± 7.3
F Ex: 7.8 ± 6.1
Con: 9.6 ± 7.9
12 weeks supervised, facility-based aerobic ex, 3×/wk, 10-
40 min/day, 75%MHR
Kingsley et al. (2005)[11] Ex: 15
Con (usual care): 14
Ex: 45 ± 9
Con: 47 ± 4
F Ex: 9 ± 10
Con: 7 ± 5
12 weeks strength training, 11 ex, 2×/wk, 1 set, 8-12 reps, 
40-80% 1RM
Munguia-Izquierdo & Legaz-
Arrese (2007)[12]
Ex: 29
Con (usual care): 24
Ex: 50 ± 7
Con: 46 ± 8
F Ex: 14 ± 10
Con: 14 ± 9
16 weeks supervised, facility-based ex, 3×/wk; 
strengthening (1-3 sets, 8-15 reps, 8-10 ex); aerobic (20-30 
min, 50-80% MHR); compliance ≥ 75%
Schachter et al. (2003)[13] Ex (sb): 56
Ex: (lb): 51
Con (monthly small group 
meetings to discuss 
fibromyalgia): 36
Ex (sb): 41.9 ± 8.6
Ex: (lb): 41.3 ± 8.7
Con: 42.5 ± 6.7
F Ex (sb): 8.6 ± 6.0
Ex (lb): 8.8 ± 6.2
Con: 8.8 ± 5.0
16 weeks home-based, low-impact aerobic ex; short bout, 
2×/day, 3×/wk, 5-15 min/session, 40-75% HRR; long bout, 
1×/day, 3×/wk, 10-30 min/session, 40-75% HRR
Tomas-Carus et al. (2007) [14] Ex: 17
Con (usual care): 17
Ex: 51 ± 10
Con: 51 ± 9
F Ex: 24 ± 9
Con: 19 ± 8
12 weeks, supervised, facility-based aerobic and 
strengthening ex, 3×/wk; aerobic, 20 min/day, 65-75% 
MHR; compliance >95%
Notes: Description of groups and subjects from each study limited to those that met the inclusion criteria; N, number of subjects; age reported as mean ( ) ± standard deviation (SD); F, females; 
M, males; Ex, Exercise; Con, Control; FM, fibromyalgia; MHR, maximum heart rate; 1RM, one-repetition maximum; HRR, heart rate reserve; lb, long bout; sb, short bout; min, minutes; wk, week; reps, 
repetitions.
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three studies and four groups in which information were
available [8,9,13], the mean between-group duration
since physician diagnosis of fibromyalgia ranged from 2.8
to 3.8 years in the exercise groups (  ± SD, 3.3 ± 0.5) and
3.6 to 4.9 years in the control groups (  ± SD, 4.2 ± 0.7).
One study reported that some participants smoked [13]
while little information was provided regarding diet,
including alcohol intake. In relation to exercise, six stud-
ies reported that none of the participants were exercising
regularly prior to participating in the study [8,9,11-14]
while one reported that some had been exercising prior
to participation [10]. Five studies appeared to include one
or more subjects who were overweight or obese [8,10-
12,14], defined as a body mass index ≥ 25 kg/m2.
Exercise Program Characteristics
A description of the characteristics of the exercise pro-
grams for each group from each study is shown in Table
2. Four groups from three studies focused on aerobic
exercise [9,10,13], one study was limited to strengthening
exercise [11], while three others included both aerobic
and strengthening exercise [8,12,14]. For those studies in
which data were available [9-14], frequency of training
ranged from two to six sessions per week (  ± SD, 3 ± 1)
with three times per week being the most common. The
duration of within-group aerobic and/or strengthening
exercise ranged from five to 50 minutes per session
[9,10,12-14] while the mean between-group range was 12
to 24 minutes per session (  ± SD, 19.2 ± 5.1) [9,12-14].
Within-group intensity of aerobic training ranged from
40% to 85% of maximum heart rate (MHR) [8-10,12-14].
The one study that was limited to strengthening exercise
reported a training intensity between 40% and 80% of one
repetition maximum (1RM) [11]. Between-groups mean
compliance, defined as the percentage of exercise ses-
sions attended, ranged from 65.9% to more than 95.0%
(  ± SD, 75.7% ± 13.5%) [8,9,12,14]. Four studies had
participants perform exercise in a pool [9,10,12,14]. For
those studies that reported data, four had participants
perform supervised, facility-based exercise [9,10,12,14],
another study with two exercise groups had participants
perform unsupervised, home-based exercise [13] and
another had participants perform primarily unsuper-
vised, home-based exercise as well as four supervised ses-
sions [9].
Findings for Global Well-Being using the FIQ
Overall results
A small, statistically significant improvement in global
well-being was observed for both per-protocol and inten-
tion-to-treat outcomes in the exercise groups (Figure 2).
No statistically significant within-group heterogeneity
was found (per-protocol, Qw = 6.04, p = 0.20, I2 = 33.8%;
intention-to-treat, Qw = 3.19, p = 0.53, I2 = 0%) and no
X
X
X
X
X
Figure 2 Forest plot for changes in global-well being. Forest plot for point estimate standardized effect size changes (Hedge's g) in global well-
being derived from the total score on the FIQ and analyzed according to per-protocol analyses and intention-to-treat analyses. The black squares rep-
resent the standardized mean difference (Hedge's g) while the left and right extremes of the squares represent the corresponding 95% confidence 
intervals. The middle of each of the two black diamond's represents the overall standardized mean difference (Hedge's g) for each type of analysis 
(per-protocol and intention-to-treat) while the left and right extremes of the diamonds represent the corresponding 95% confidence intervals.
Study name Group by
Analysis Type
Statistics for each study Point estimate and 95% CI
Point Lower Upper 
estimate limit limit
Da Costa et al. (2005) intention-to-treat -0.39 -0.84 0.05
Gowans et al. (2001a) intention-to-treat -0.80 -1.38 -0.22
King et al. (2002a) intention-to-treat -0.22 -0.68 0.23
Kingsley et al. (2005) intention-to-treat -0.27 -1.01 0.46
Schachter et al. (2003a) intention-to-treat -0.24 -0.54 0.06
intention-to-treat -0.34 -0.53 -0.14
Gowans et al. (2001b) per-protocol -0.79 -1.52 -0.06
King et al. (2002b) per-protocol 0.24 -0.34 0.83
Munguia-Izquierdo (2007) per-protocol -0.46 -1.01 0.09
Schachter et al. (2003b) per-protocol -0.46 -0.83 -0.09
Tomas-Carus et al. (2007) per-protocol -0.55 -1.23 0.14
per-protocol -0.39 -0.69 -0.08
-2.00 -1.00 0.00 1.00 2.00
Favors Exercise Favors Control
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statistically significant differences between per-protocol
and intention-to-treat outcomes were observed (Qb =
0.07, p = 0.80). No study was excluded from the meta-
analysis because of a lack of data (selective reporting) for
the FIQ.
Using the CLES, 61% (per-protocol analysis) and 60%
(intention-to-treat analysis) of participants in the exercise
group would score higher than control group participants
if chosen at random. Changes were equivalent to an odds
ratio (OR) improvement of 51% (OR = 0.49, 95% CI, 0.27
to 0.87) based on the per-protocol approach and 47% (OR
= 0.53, 95% CI, 0.36 to 0.77) based on intention-to-treat
analysis. Relative to baseline values for the FIQ, exercise
minus control group improvements were equivalent to
8.2% for per-protocol analysis and 7.2% for intention-to-
treat analysis.
Publication bias
When per-protocol results were adjusted for potential
publication bias (one imputation), results remained sta-
tistically significant (g, -0.32, 95% CI -0.62 to -0.02). No
adjustment for publication bias was needed for intention-
to-treat results.
Sensitivity analysis
With each outcome deleted from the model once, results
remained statistically significant across all deletions for
both per-protocol and intention-to-treat analyses (Figure
3).
Cumulative meta-analysis
When ranked by year, cumulative meta-analysis demon-
strated that results have been statistically significant since
2003 for both per-protocol and intention-to-treat analy-
ses (Figure 4).
Discussion
Using intention-to-treat and per-protocol analyses, the
results of this study suggest that exercise, as assessed by
the FIQ, improves global well-being in community-dwell-
ing women with fibromyalgia. These findings are rein-
forced by the fact that results have been consistent since
2003 and that all findings remained statistically signifi-
cant when each study was deleted from the model once.
The fact that no statistically significant difference was
found between per-protocol and intention-to-treat out-
comes is important given that recent research has sug-
gested that excluding participants from the analysis in
randomized controlled trials often results in biased esti-
mates of treatment effects when the results of these stud-
ies are pooled in systematic reviews [21]. These overall
findings are also similar to an earlier meta-analysis that
used multiple measures to assess global well-being and
did not differentiate between per-protocol and intention-
to-treat analyses [7]. The similar findings between both
reviews are important since it is not uncommon for the
results of systematic reviews on the same topic to differ
[43]. This should give practitioners more confidence in
the expected benefits of exercise on global well-being in
women with fibromyalgia.
The results of this study suggest that a low risk of bias
exists for incomplete outcome data, selective reporting,
and between-group differences in baseline measures for
the FIQ. In contrast, a high risk of bias was observed for
blinding while sequence generation and allocation con-
cealment was unclear in more than 50% of the studies.
Consequently, it would seem appropriate to suggest that
future exercise intervention studies apply appropriate
blinding procedures as well as applying and clearly
reporting adequate methods for sequence generation and
allocation concealment. However, these results should be
interpreted cautiously. In order to provide a greater
degree of flexibility across a variety of different research
domains, a substantial degree of subjectivity is allowed in
the use of the Cochrane Collaborations bias assessment
tool [32]. Consequently, other individuals assessing the
same studies may arrive at different conclusions regard-
ing the risk of bias across the different domains. For
example, while studies were considered high risk if they
did not blind participants, personnel and outcome asses-
sors to group assignment, others may have chosen to
classify studies as low risk if only the outcome assessor or
outcome assessor and other study personnel were
blinded. This approach would appear plausible given that
it is extremely difficult, if not impossible, to blind partici-
pants to group assignment in exercise intervention stud-
ies. Nevertheless, the risk for bias still exists and may be
especially problematic for subjective measures such as
the FIQ as opposed to a more objective measure such as
body weight. Thus, this form of bias is not a study-spe-
Figure 3 Forest plot for changes in global-well being with each 
study deleted once. Point estimate standardized effect size changes 
(Hedge's g) in global well-being derived from the total score on the FIQ 
and analyzed according to per-protocol and intention-to-treat and 
analyses with each study deleted from the model once. The black 
squares represent the standardized mean difference (Hedge's g) while 
the left and right extremes of the squares represent the corresponding 
95% confidence intervals. The middle of each of the two black dia-
mond's represents the overall standardized mean difference (Hedge's 
g) for each type of analysis (per-protocol and intention-to-treat) while 
the left and right extremes of the diamonds represent the correspond-
ing 95% confidence intervals.
Study name Group by
Analysis Type
Point estimate (95% 
CI) with study removedLower Upper 
Point limit limit
Da Costa et al. (2005) intention-to-treat -0.33 -0.58 -0.08
Gowans et al. (2001a) intention-to-treat -0.27 -0.48 -0.07
King et al. (2002a) intention-to-treat -0.37 -0.61 -0.13
Kingsley et al. (2005) intention-to-treat -0.35 -0.58 -0.12
Schachter et al. (2003a) intention-to-treat -0.41 -0.68 -0.14
intention-to-treat -0.34 -0.53 -0.14
Gowans et al. (2001b) per-protocol -0.34 -0.59 -0.09
King et al. (2002b) per-protocol -0.51 -0.78 -0.25
Schachter et al. (2003b) per-protocol -0.34 -0.67 -0.01
Munguia-Izquierdo (2007) per-protocol -0.37 -0.66 -0.08
Tomas-Carus et al. (2007) per-protocol -0.36 -0.64 -0.09
per-protocol -0.39 -0.69 -0.08
-1.00 -0.50 0.00 0.50 1.00
Favors Exercise Favors Control
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cific problem, but rather, inherent to exercise interven-
tion studies. In addition, while a low risk of bias was
found for selective reporting of outcomes, only one out-
come was the primary focus of the current meta-analysis.
In contrast, the inclusion of multiple outcomes, for exam-
ple changes in lipids and lipoproteins, might result in
more studies being classified as high versus low risk. The
same may be true for the domain "other forms of bias" as
the present investigation limited this domain to between-
group differences in baseline values in global well-being
as assessed by the FIQ. Finally, while selective reporting
should ideally be determined by examining the study pro-
tocol [32], the identification of study protocols was not
possible in the current investigation. Therefore, the
recent recommendations of Hartling et al. [33] were
adhered to whereby the degree of risk was based on
whether the FIQ was described in the methods section
and reported in the results. By adhering to the study pro-
tocol approach, all studies would have been categorized
as having an unclear versus low risk for bias.
It has recently been suggested that a 14% change in the
total score on the FIQ is clinically relevant [44]. While the
relative changes in the current meta-analysis ranged
between 7.2% and 8.2%, they may still be clinically impor-
tant given that no gold standard exists for determining
such. In addition, numerous other benefits can be derived
from exercise while the risks associated with participa-
tion in a program of regular exercise are minimal [45].
Given the former, it would seem plausible to suggest that
participation in exercise programs similar to those
included in the current meta-analysis should yield the
same improvements in global well-being. However, the
ability to statistically examine the issue of dose-response,
including intensity, was not possible because of the small
number of studies included. As suggested by the recent
Department of Health and Human Services Physical
Activity Guidelines Advisory Committee Report [25],
additional studies are needed to determine the optimal
length, frequency, intensity and duration necessary for
maximizing benefits among adults with arthritis and
other rheumatic conditions, including fibromyalgia. This
includes an examination of how to progressively increase
the dose of activity, including intensity, so that maximum
benefits can be obtained. Until such information is avail-
able, it may be prudent to follow the general guidelines of
the American College of Sports Medicine regarding exer-
cise [23,24].
While the results of this meta-analysis are encouraging,
they must be interpreted while taking other issues into
account. For example, it is probably not possible to gener-
Figure 4 Cumulative meta-analysis for changes in global well-being. Cumulative meta-analysis ranked by year, for point estimate standardized 
effect size changes (Hedge's g) in global well-being derived from the total score on the FIQ and analyzed according to per-protocol and intention-to-
treat and analyses. The black squares represent the standardized mean difference (Hedge's g) while the left and right extremes of the squares repre-
sent the corresponding 95% confidence intervals. The middle of each of the two black diamond's represents the overall standardized mean difference 
(Hedge's g) for each type of analysis (per-protocol and intention-to-treat) while the left and right extremes of the diamonds represent the correspond-
ing 95% confidence intervals. Studies are added one at a time according to date of publication and the results summarized as each new study is added.
Study name Group by
Analysis Type
Cumulative statistics Cumulative point estimate (95% CI)
Lower Upper 
Point limit limit
Gowans et al. (2001a) intention-to-treat -0.80 -1.38 -0.22
King et al. (2002a) intention-to-treat -0.48 -1.05 0.08
Schachter et al. (2003a) intention-to-treat -0.36 -0.66 -0.05
Da Costa et al. (2005) intention-to-treat -0.34 -0.55 -0.13
Kingsley et al. (2005) intention-to-treat -0.34 -0.53 -0.14
intention-to-treat -0.34 -0.53 -0.14
Gowans et al. (2001b) per-protocol -0.79 -1.52 -0.06
King et al. (2002b) per-protocol -0.18 -0.69 0.33
Schachter et al. (2003b) per-protocol -0.33 -0.66 -0.00
Munguia-Izquierdo (2007) per-protocol -0.36 -0.64 -0.09
Tomas-Carus et al. (2007) per-protocol -0.39 -0.63 -0.14
per-protocol -0.39 -0.69 -0.08
-2.00 -1.00 0.00 1.00 2.00
Favors Exercise Favors Control
Kelley et al. BMC Public Health 2010, 10:198
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alize the findings of this meta-analysis to men with fibro-
myalgia given that few studies included men. Despite the
lower prevalence in men [2], it would seem appropriate to
suggest that future research on the effects of exercise on
global well-being in men is necessary.
Because of a lack of statistically significant heterogene-
ity (p > 0.10) and inconsistency (<50%) the results of stud-
ies in which the content of the exercise intervention
varied, i.e., aerobic and/or strengthening exercise, super-
vised and/or non-supervised sessions, home and/or facil-
ity based exercise, were pooled. While a lack of
heterogeneity and inconsistency does not exclude one
from conducting sensitivity and/or subgroup analyses,
this was not possible given the small number of studies
included as well as the lack of data available for the vari-
ables of interest. Given the former, it is suggested that
future randomized controlled trials include and compare
exercise interventions of varying content so as to deter-
mine their potential impact on global well-being in adults
with fibromyalgia. In addition, future studies should
report complete data for these variables as they may have
an effect on global well-being.
To reduce potential bias, the current meta-analysis was
limited to only those studies in which the FIQ was used.
However, it is possible that such a limitation could have
caused selection bias. One possible alternative would
have been to include studies that used other measures for
assessing global well-being and then perform some type
of sensitivity or subgroup analyses to see what effect, if
any, the inclusion of such may have had on global well-
being outcomes. However, it's important to realize that
these types of analyses are observational in nature
because studies are not randomly assigned to moderators
[46]. Consequently, such analyses do not support causal
inferences. In meta-analysis, causal inferences can only
be inferred from the overall results of randomized con-
trolled trials [47].
Finally, the exact search strategy for the identification
of randomized trials as recommended by the Cochrane
Collaboration was not followed [32]. Consequently, the
possibility exists that relevant studies may have been
missed. However, this seems unlikely given the exhaustive
search methods employed.
Conclusions
The results of this study suggest that exercise improves
global well-being in community-dwelling women with
fibromyalgia. However, additional research on this topic
is needed, including research in men as well as optimal
exercise programs for improving global well-being in
adults.
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